US 10857174
Morpholino oligonucleotides useful in cancer treatment
granted A61KA61K31/4162A61K31/711
Quick answer
US patent 10857174 (Morpholino oligonucleotides useful in cancer treatment) held by United States Government as represented by the Department of Veterans Affairs expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Government as represented by the Department of Veterans Affairs
- Grant date
- Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4162, A61K31/711, A61K9/0019, A61P